Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Low-temperature Labels

May 19, 2011 11:31 am | Product Releases | Comments

Computype, Inc. launched the Cryo Hold TS994, a label for plastic and glass labware made to withstand extreme conditions in the laboratory environment, that is suitable for flexographic imaging, thermal-transfer imaging, and automatic application.

TOPICS:

Lilly Announces LY2127399 Data Presentation

May 19, 2011 11:23 am | News | Comments

Eli Lilly and Company announced Phase 1 data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.

TOPICS:

MOR202 Data Shows Promising Results

May 19, 2011 11:19 am | News | Comments

MorphoSys AG announced promising pre-clinical data on MOR202 a fully human anti-CD38 antibody. By combining MOR202 with two approved drugs for the treatment of multiple myeloma, the anti-cancer activity of the antibody could be enhanced.

TOPICS:
Advertisement

NJ Pushing Stricter Botox Law

May 19, 2011 11:12 am | by Josh Lederman | News | Comments

Minors in New Jersey won't be able to get Botox injections without a doctor saying it's medically necessary under a bill moving through the Assembly.

TOPICS:

FBI Investigating 1982 Tylenol Deaths

May 19, 2011 11:09 am | News | Comments

The FBI has requested a DNA sample from "Unabomber" Ted Kaczynski as part of its investigation into the 1982 deaths of seven Chicago-area people who took cyanide-laced Tylenol from packages that had been tampered with, officials said.

TOPICS:

BLT Mice A Better Model of HIV Transmission

May 19, 2011 11:05 am | News | Comments

A new study further validates the use of humanized BLT mice in the fight to block HIV transmission. Humanized BLT mice have a fully functioning human immune system and can be infected with HIV in the same manner as humans.

TOPICS:

New Cell Therapy to Prevent Organ Rejection

May 19, 2011 11:02 am | News | Comments

Researchers have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.

TOPICS:

Aspirin, Simvastatin No Help in PAH

May 19, 2011 11:00 am | News | Comments

An NIH-funded study has found that despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension.

TOPICS:
Advertisement

New Treatment Beneficial in Advanced Colon Cancer

May 19, 2011 10:56 am | News | Comments

Research physicians believe that a new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed.

TOPICS:

Quay Adds Equipment, GMP Compliance

May 19, 2011 10:44 am | News | Comments

Quay Pharmaceuticals has invested in a variety of new equipment as part of its move to its purpose-designed facility in Deeside, U.K., which was officially opened last year.

TOPICS:

Pharmatek Adds Spray Drying to Development Services

May 19, 2011 10:41 am | News | Comments

Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities, purchasing a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.

TOPICS:

ERT Awarded over $10 Million of ePRO Business

May 19, 2011 10:36 am | News | Comments

ERT has signed three contracts with pharmaceutical companies for its electronic patient reported outcomes (ePRO) business , totaling over $10 million.

TOPICS:

DaVita Clinical Research Opens Cleanroom

May 19, 2011 10:31 am | News | Comments

DaVita Clinical Research has completed a Phase I-IIa cleanroom to comply with USP 797 high risk regulations demonstrating the cleanroom meets the requirements to handle compounds in a safe and efficient manner.

TOPICS:

PPD Expands Product Development Consulting Services

May 19, 2011 10:27 am | News | Comments

PPD, Inc. announced it has established four practice areas through PPD Consulting-biosimilars, adaptive trial design, China regulatory strategy, and cardiovascular outcomes studies.

TOPICS:

Ockham Appoints Vice-President of Preclinical and Regulatory Affairs

May 19, 2011 10:23 am | News | Comments

Harman Dubé has joined Ockham as vice-president of pre-clinical and regulatory affairs within the OckhamCRO division.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading